Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04642183 · ClinicalTrials.gov registry record
Single In-Clinic Encounter With the Notal Vision Home OCT
A clinical trial, sponsored by Notal Vision.
- Completed
- Registry status
- 70
- Enrollment target
NCT04642183 is a clinical trial that has completed, run by Notal Vision. The registered enrollment target is 70 participants.
The verdict
NCT04642183 has completed, sponsored by Notal Vision.
- COMPLETED
- Registry status
- 70 participants
- Enrollment target
Study Summary
this is a single In-Clinic Encounter With the Notal Vision Home OCT study. The study population will include up to 50 Age-related Macular Degeneration patients diagnosed with wet NV-AMD in at least one eye at the time of enrollment. All enrolled subjects should have at least one eye with active (wet) CNV (SRF and/or IRF) at the time of enrollment. All subjects will be enrolled at 1 site in the United States. in this study patients will be placed in a room with the Notal Vision Home OCT device and following a completion of a self tutorial will perform 3 unsupervised self-scans on each study eye (with a rest of \~5 minutes between self-scans). at the end of the testing sessions, the subject will be asked to complete subject user questionnaire.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 70 participants |
| Start Date | 2020-11-16 |
| Est. Completion | 2021-09-30 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04642183
The ClinicalTrials.gov registry entry for NCT04642183 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 70 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Notal Vision, which has 11 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT04642183 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04642183 about?
NCT04642183 is a clinical study titled "Single In-Clinic Encounter With the Notal Vision Home OCT". this is a single In-Clinic Encounter With the Notal Vision Home OCT study. The study population will include up to 50 Age-related Macular Degeneration patients diagnosed with wet NV-AMD in at least one eye at the time of enrollment. All enrolled subjects should have at least one eye with active (wet...
What is the current status of trial NCT04642183?
This trial is currently completed. The enrollment target is 70 participants. The study started on 2020-11-16. Estimated completion is 2021-09-30.
Who is sponsoring clinical trial NCT04642183?
This trial is sponsored by Notal Vision, which has 11 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.